𝔖 Bobbio Scriptorium
✦   LIBER   ✦

P3.40. Cross-resistance to platinums in a cisplatin-resistant oral squamous carcinoma cell line, H-1R

✍ Scribed by Ogoshi, K.; Uzawa, K.; Yamatoji, M.; Kasamatsu, A.; Negoro, K.; Wada, T.


Book ID
119336974
Publisher
Elsevier Science
Year
2009
Weight
51 KB
Volume
3
Category
Article
ISSN
1744-7895

No coin nor oath required. For personal study only.


πŸ“œ SIMILAR VOLUMES


Mechanism of cross-resistance to cisplat
✍ Shivendra V. Singh; Bing H. Xu; Jitesh P. Jani; Erling O. Emerson; Mary G. Backe πŸ“‚ Article πŸ“… 1995 πŸ› John Wiley and Sons 🌐 French βš– 730 KB

This study was undertaken to elucidate the mechanism@) of cross-resistance to cisplatin (CDDP) in a mitomycin C (MMC)resistant human bladder cancer cell line, J82/MMC. The J82/ MMC cell line displayed 2-to 3-fold cross-resistance to CDDP and carboplatin when compared to the parental )82/WT cells. Dr

Effect of novobiocin on cisplatin cytoto
✍ Steven De Jong; Hetty Timmer-Bosscha; Elisabeth G. E. De Vries; Nanno H. Mulder πŸ“‚ Article πŸ“… 1993 πŸ› John Wiley and Sons 🌐 French βš– 948 KB

## Abstract Studies were performed to determine whether novobiocin can be used to enhance cisplatin (CDDP) cytotoxicity in a human small‐cell lung carcinoma cell line, GLC~4~/CDDP, resistant to CDDP. Continuous incubation with novobiocin enhanced the cytotoxicity of CDDP treatment 1.9‐fold in the p